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KAJIAN PEMIAWAIAN, KESELAMATAN DAN ANTI-OBESITI 
TERHADAP EKSTRAK PIPER SARMENTOSUM ROXBURGH 
 
ABSTRAK 
Kajian ini merangkumi kawalan kualiti, pemiawaian, keselamatan dan aktiviti 
biologi menggunakan ekstrak Piper sarmentosum. Ekstrak menggunakan etanol, etanol 
(50%) dan air telah dipiawai dan dikaji menggunakan assai anti-obesiti dan anti-
hiperlipidemik. Ujian fiziko-kimia, had, cap jari kualitatif dan kuantitatif dijalankan 
menggunakan kaedah spektroskopi dan kromatografi. Kandungan metabolit primer dan 
sekunder dalam ekstrak ditentukan. Ekstrak telah dianalisis bagi kandungan asaron 
menggunakan HPLC dan FT-IR. Analisis kemometri (PCA dan HCA) diaplikasikan ke 
dalam pemiawaianan. Ekstrak terpiawai disaring secara in vitro menggunakan assai 
sitotoksisiti udang brin (BSLA), perencatan lipase pankreas (PPL) dan aktiviti anti-
angiogenesis. Assai anti-obesiti dan anti-hiperlipidemik dijalankan secara in vivo dalam 
tikus teraruh diet tinggi lemak (HFD). Cap jari tersendiri bagi tumbuhan ini serta 
kehadiran vitexin dan naringenin diperhatikan dalam ekstrak. Sampel dari Pulau Pinang 
dan Perak memenuhi had yang dibenarkan untuk ujian keselamatan. HPLC 
menunjukkan kandungan vitexin yang berbeza (0.03 ± 0.002 – 0.98 ± 0.01% brt/brt) 
dalam ekstrak P. sarmentosum. Naringenin ditemui dalam ekstrak etanol bagi sampel 
dari Perlis dan Terengganu (0.06 ± 0.001% dan 0.12 ± 0.0003% brt/brt). Ekstrak dari 
Pulau Pinang menunjukkan jumlah polisakarida (87.71 ± 0.26 – 111.10 ± 0.06 mg/g), 
protein (19.32 ± 0.25 – 39.81 ± 0.40 mg/g), glikosaponin (15.55 ± 1.60 – 203.73 ± 0.39 
mg/g), fosfolipid (0.00 ± 0.00 – 46.25 ± 0.92 mg/g), fenolik (19.88 ± 0.18 – 37.39 ± 0.54 
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mg/g) dan flavonoid (5.65 ± 0.04 – 43.66 ± 0.11 mg/g) yang tertinggi, seterusnya dipilih 
sebagai ekstrak terpiawai. Kaedah baru HPLC untuk penilaian dua penanda toksik, α- 
dan β-asaron telah dibangun dan disahkan. Ekstrak etanol dan SFE mengandungi jumlah 
asaron yang tertinggi diikuti ekstrak etanol (50%) dan tiada dalam ekstrak akueus. Oleh 
itu, ekstrak akueus telah dipertimbangkan sebagai selamat untuk digunakan oleh 
manusia. FT-IR yang digabungkan dengan PCA dan HCA mendedahkan bahawa ekstrak 
etanol dan SFE berada dalam kelompok yang sama dengan asaron dan ini berkait rapat 
dengan jumlah asaron dalam ekstrak tersebut. Saringan sitotoksisiti menggunakan assai 
BSLA menunjukkan ekstrak etanol, etanol (50%) dan akueus terpiawai mempunyai 
aktiviti sitotoksisiti yang rendah selepas 24 jam rawatan. Perencatan PPL secara in vitro 
menunjukkan aktiviti perencatan ringan kepada sederhana bagi ekstrak etanol (50%) 
(21.81 ± 1.25%) dan akueus (9.41 ± 1.41%). Aktiviti anti-angiogenesis menggunakan 
assai cincin tikus ke atas ekstrak etanol (50%) menunjukkan aktiviti perencatan 
sebanyak 26.50 ± 0.89% manakala ekstrak akueus menunjukkan 43.40 ± 0.93% aktiviti 
perencatan. Rawatan in vivo dengan ekstrak etanol (50%) dan akueus terpiawai selama 
45 hari mempengaruhi metabolisme kolesterol dalam tikus teraruh HFD. Dos 500 mg/kg 
berjaya menurunkan peratusan peningkatan berat badan, indeks jisim tubuh, profil lipid 
dan berat tisu adipos secara signifikan berbanding tikus HFD yang tidak dirawat. Tiada 
gejala penyakit hepar berlemak diperhatikan pada dos 250 dan 500 mg/kg. Sebagai 
kesimpulan, daripada kajian ini maklumat berkenaan kualiti, keselamatan dan 
keberkesanan ekstrak P. sarmentosum telah diperolehi. Ekstrak etanol (50%) dan akueus 
terpiawai menunjukkan hasil positif bagi kajian berkaitan obesiti secara in vitro dan in 
vivo. 
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STANDARDIZATION, SAFETY AND ANTI-OBESITY STUDIES OF 
PIPER SARMENTOSUM ROXBURGH EXTRACTS 
 
ABSTRACT 
This study involves quality control, standardization, safety and biological 
activities using Piper sarmentosum extracts. Extracts using ethanol, ethanol (50%) and 
water were standardized and further evaluated using anti-obesity and anti-
hyperlipidemic assays. Physico-chemical, limit test, qualitative and quantitative plant 
fingerprint was performed using spectroscopic and chromatographic techniques. The 
contents of primary and secondary metabolites in the extracts were determined. The 
extracts were analyzed for asarones content using HPLC and FT-IR. Chemometrics 
(PCA and HCA) were applied in standardization. Standardized extracts were screened in 
vitro for cytotoxicity against brine shrimp assay (BSLA), pancreatic lipase (PPL) 
inhibition and anti-angiogenesis activities. The anti-obesity and anti-hyperlipidemic 
assays were performed in vivo on high fat diet (HFD) induced rats. Distinctive 
fingerprint of the plant materials and the presence of vitexin and naringenin in the 
extracts were observed. Samples from Penang and Perak were complying with the 
acceptable safety limit tests. HPLC shows varying amount of vitexin (0.03 ± 0.002 – 
0.98 ± 0.01% wt/wt) in P. sarmentosum extracts. Naringenin was detected in ethanol 
extracts from Perlis and Terengganu (0.06 ± 0.001% and 0.12 ± 0.0003% wt/wt), 
respectively. Extracts from Penang (PSP) showed the highest total polysaccharides 
(87.71 ± 0.26 – 111.10 ± 0.06 mg/g), proteins (19.32 ± 0.25 – 39.81 ± 0.40 mg/g), 
glycosaponins (15.55 ± 1.60 – 203.73 ± 0.39 mg/g), phospholipids (0.00 ± 0.00 – 46.25 
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± 0.92 mg/g), phenolics (19.88 ± 0.18 – 37.39 ± 0.54 mg/g) and flavonoids (5.65 ± 0.04 
– 43.66 ± 0.11 mg/g), respectively thus, selected as the standardized extracts. A new 
HPLC method for evaluation of two toxic markers, α- and β-asarone was developed and 
validated. Ethanol and SFE extracts contained the highest amount of asarones followed 
by ethanol (50%) and absent in water extracts. Hence, water extract was considered as 
safe for human consumption. FT-IR combined with PCA and HCA revealed that ethanol 
and SFE extracts were clustered together with asarones and correlated with the amount 
of asarones in the extracts. Cytotoxicity screening using BSLA showed that the 
standardized ethanol, ethanol (50%) and water extracts exhibited low cytotoxicity after 
24 hours of treatment. In vitro PPL inhibition of P. sarmentosum showed mild to 
moderate inhibition activity in ethanol (50%) (21.81 ± 1.25%) and water extracts (9.41 ± 
1.41%), respectively. Anti-angiogenesis activity using rat aortic ring assay on ethanol 
(50%) extract showed 26.50 ± 0.89% inhibition whereas water extract showed 43.40 ± 
0.93% inhibition. The in vivo treatment with standardized ethanol (50%) and water 
extracts for 45 days influenced the cholesterol metabolism in HFD rats. Doses of 500 
mg/kg significantly lower the percentage of total body weight increase, body mass 
index, lipid profiles and adipose tissue weight compared to HFD untreated rats.  No sign 
of fatty liver disease were observed at doses of 250 and 500 mg/kg. As conclusion, 
information on the quality, safety and efficacy of P. sarmentosum extracts were 
obtained. The standardized ethanol (50%) and water extracts shows positive results for 
in vitro and in vivo obesity-related studies. 
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CHAPTER ONE 
INTRODUCTION 
1.1  Natural product 
Natural product can be defined as chemical substances that are derived from 
natural sources such as plants, animals and microorganisms (Ji et al., 2009). It includes a 
wide ranges of substances from vitamins, mineral, metabolites and probiotics. Natural 
products have been utilized since long time ago to treat various diseases and were 
applied in modern medicine as source of drugs such as aspirin, codeine and digoxin (Li, 
2009). Plants contain mixture of phytochemical constituents including primary 
metabolites such as carbohydrates, protein, lignins, nucleic acid and lipids; secondary 
metabolites such as terpenoids, alkaloids, glycosides, flavonoids and tannins (Ibrahim, 
2006). Primary metabolites usually involved in normal development and reproduction of 
the cell. It plays an important role in cell function as a growth unit for all cell 
components (Hussain, 2008). 
 
The secondary metabolites play a role in defense mechanism of the plant against 
predators such as insects and animals, as well as a source of attraction for pollination. 
They have been reported to possess pharmaceutical and therapeutic properties such as 
antibacterial, antifungal, antivirus, antitumor and many more that it has caught interest 
among organic chemistry researchers (Fasihuddin & Hasmah, 1993). These secondary 
metabolites can be isolated as pure compounds and used as therapeutic agents in 
combating diseases. Among all, alkaloids contain highest pharmacological potential as 
they have been used extensively as analgesic agents, anticholinergics, antihypertensives, 
antimalarials, antitumors, cardiac inhibitors, diuretic agents, narcotic analgesics and 
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tranquilizers (Fasihuddin & Hasmah, 1993). Apart from alkaloids, metabolites from 
phenolic and flavonoid classes are well known to possess antioxidant properties which 
help combat various metabolic diseases. Flavonoids subclasses such as anthocyanidins, 
flavon-3-ols, flavones, apigenin, flavan-3-ols, flavanones), theaflavins and hydroxy 
cinnamates that present abundantly in food such as fruits, vegetables and beverages have 
been reported to possess potent antioxidant activity (Rice-Evans et al., 1997). These 
primary and secondary metabolites have made natural products a popular and effective 
source of remedy to treat various diseases and disorder. 
 
Since centuries, natural products were traditionally used as folklore medicines. 
With the growing of modern sciences, most of these natural substances were 
incorporated into the development of modern drugs based on the traditional uses. 
Thousands of scientific researches were conducted all over the world in order to develop 
drugs from herbal sources. From 1981 to 2006, approximately 70% new chemicals 
entities were reported from the study of natural products (Newman & Cragg, 2007). 
From year 1940 to 2010, about 48.6% of anticancer drugs were produced and derived 
from natural products (Newman & Cragg, 2012).  
 
1.2  Standardization of Herbal Products 
Herbal products have been widely marketed as herbal supplements and drugs for 
treating various diseases. In 2013, World Health Organization (WHO) reported that 
there is high demand for medicinal plants, currently 14 billion USD annually and 
estimated that the market demand will reach 5 trillion USD by the year 2050. These 
trends was observed in  developing and developed countries, whereby people shifted to 
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herbal drugs due to high prices and side effects of synthetic drugs (Aneesh et al., 2009). 
Despite the health benefit of herbal product, there are still lack of information on the 
quality, safety and efficacy of the products. Several issue of side effects and adulteration 
of herbal products have been reported due to active constituents of the herbs, 
contaminants and herb-drug interactions (Bent, 2008). Unlike the synthetic drugs; herbal 
products contain thousands of chemical constituents that may produce the desirable 
effects for certain claims. These complex combinations of chemical constituents were 
consistently inconsistent from batch to batch. The inconsistency of herbal products were 
affected by several factors such as climate, geographical variations, harvesting time and 
post-harvesting handling, storage of the material and manufacturing processes. Safety of 
the material is another important measures as the material may be dangerous due to 
internal factors such as toxic constituents of the plant and external factors resulted from 
the adulteration of heavy metals, microorganisms and pesticides uses (Jadhav & Patil, 
2003). 
 
Knowing the importance of herbal product consistency, standardization protocols 
of herbal products have been established. Standardization of herbal products is a process 
to maintain batch-to-batch reproducibility and guaranteed potency (Hussain, 2008). 
Herbal standardization process cover from the cultivation to extracts development. 
According to guidelines developed by WHO, (1998), standardization of herbal materials 
must cover aspects ranging from the authentication, quality, safety and efficacy. 
Information on the taxonomic identification and authentication of plant material (source, 
age, and geographic information), fumigant or pesticides usage, parts of plant used, 
morphological and microscopic examination must be documented. Quality and safety 
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parameters include the harvesting and post harvesting handling, moisture content, 
microbial and heavy metal (lead, cadmium, arsenic and mercury) contamination, 
fingerprint profiling of the plant and the identification of marker compounds. Profiling 
and standardization of herbal products are commonly performed using markers. There 
are eight categories of chemical markers which are therapeutic, bioactive, synergistic, 
characteristic, main components, correlative components, toxic components and general 
components (Li et al., 2008). Assay of the known therapeutic activity should be 
documented to support the efficacy of the herbal products based on the traditional 
claims. 
 
1.3  Justification of Study 
According to National Pharmaceutical Control Bureau (NPCB) website, there are 
3 products registered containing P. sarmentosum named Manjakani Plus Tea 
(MAL20021460TC) claimed as treatment for joint ache, women personal hygiene and 
for slimming purpose, AK-FM100G (MAL09021114TC) and HPA Piper 
(MAL10070661T) for general health supplements. This showed that P. sarmentosum is 
currently used as commercialized medicinal plants. To the best of our knowledge, there 
is still lack of information on the quality control and standardization reported from this 
plant. This study was conducted to set the standardization parameters for P. 
sarmentosum extracts in order to ascertain the high quality and reproducible efficacy 
from batch-to-batch materials.  
 
From previous study, a number of chemical constituents have been isolated from 
this plant. One of the compound reported was asarone (Parmar et al., 1997; 
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Subramaniam et al., 2003), which was reported to possess toxic effects if consumed 
above the limit stated by the health authorities (115 µg/day) (Agency, 2005; Unger & 
Melzig, 2012). In this study, standardization parameters were performed to assess and 
profile the α- and β-asarone in P. sarmentosum ethanol, ethanol (50%) and water 
extracts to produce asarones-free extracts or to the lowest amount possible.   
 
The chloroform fraction of this plant was patented as anti-obesity agent through 
anti-angiogenesis activity (Patent Number WO2011112067A1) (Zhari & Khalid, 2011). 
However the extract used was not allowed for commercialization due to the usage of 
toxic organic solvent. The present study provides the analysis of the standardized P. 
sarmentosum ethanol (50%) and water extracts for anti-hyperlipidemic and anti-obesity 
activities in vitro and in vivo. The previous study on P. sarmentosum by Hussain, (2008) 
focused on the ethanol extract from leaf, root, stem and fruit; and its organic fractions 
for anti-oxidant, antibacterial, hepatoprotective, anti-angiogenesis activities, 
pharmacokinetic and stability study with reference to three amides (pellitorine, 
sarmentine and sarmentosine) as chemical markers. The present study focused on the 
authentication, standardization and method of analysis of P. sarmentosum extracts using 
ethanol, ethanol (50%) and water with reference to primary and secondary metabolites 
and vitexin, naringenin, α- and β-asarone as chemical markers for anti-obesity related 
activities. With this study, it is hope that the contribution can be made not only to utilize 
the potential of local herbs but also provide a comprehensive data for the 
standardization, scientific evaluation and safety assessment of this plant.     
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1.4  Objectives of Study 
1. To profile and standardize P. sarmentosum leaf ethanol, ethanol (50%) and water 
extracts from five locations. 
2. To analyze the presence of asarones in P. sarmentosum ethanol, ethanol (50%) and 
water extracts from different locations, plant parts and water extracts of various 
extraction methods. 
3. To screen the cytotoxicity, pancreatic lipase inhibition and anti-angiogenesis activities 
of the standardized P. sarmentosum leaf ethanol, ethanol (50%) and water extracts. 
4. To evaluate the standardized leaf ethanol (50%) and water extracts for anti-obesity 
and anti-hyperlipidemic activities in high fat diet induced Sprague Dawley rats.  
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CHAPTER TWO 
LITERATURE REVIEW 
 
2.1  Piper sarmentosum 
2.1.1  Taxonomic Classification 
Taxonomically, this plant is classified as the following scheme: 
Kingdom  :  Plantae 
Order   :  Piperales 
Family   : Piperaceae 
Genus   : Piper 
Species  : Piper sarmentosum Roxburgh 
Synonym                     : Piper albispicum C. DC., Piper baronii C. DC., Piper 
brevicaule C. DC., Piper lolot C. DC., Piper pierrei, C. 
DC., Piper saigonense C. DC. (The Plant List, 2010).  
Common name :  Malaysia: Daun Kadok, Sirih Dukok, Akar Bugu, Kadok 
Batu, Mengkadak, Kudak, Chabai; Indonesia: Kadok, 
Karuk; Thailand: Chaa Phluu, Phluu Ling, Nom Wa; 
Philippines Patai-butu; Vietnam: La Lot; Java: Cabean; 
Cambodia Mõrech An-sai (Seidemann, 2005; Muhamad & 
Mustafa, 2010). 
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2.1.2  Plant Description 
 
 
 
Figure 2.1 Picture of P. sarmentosum leaves. 
 
Piper sarmentosum is a terrestrial, creeping herbaceous shrub. P. sarmentosum 
can be found in the tropical and semitropical country of the world, such as the Asian and 
South East Asia regions. This plant is widely found in Malaysia, Indonesia, Thailand, 
Cambodia, Laos, India, Philippines and Vietnam (Chalal et al., 2011; Chaveerach et al., 
2006; Seyyedan et al., 2013; Wiart, 2006). The plant has glabrous, slender and long 
branches which creeping or erect along the ground. Generally, the plant has a 
characteristic aromatic odour and pungent taste. In villages, it can be found as weed 
under shady and damp places. The plant can grow up to 30 - 80 cm tall. The leaves are 
dark green, heart shaped, simple, alternate and cordate with size ranging about 5 to 10 
cm wide and 7-15 cm long. The inflorescences are 5 mm long nerves. The fruit is ovoid 
berry, green and red with 4 mm x 3 mm drupes. The flower has a unisexual ovary; both 
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male and female flowers are about 0.7 cm length, white, short spikes, dense, blunt and 
cylindrical in procumbent branches (Wee, 1992).  
 
2.1.3  Traditional Uses 
P. sarmentosum is well known in South East Asian countries due to its culinary 
and medicinal use. Different parts of the plant (leaf, fruit, root, and stem) were reported 
from folklore medicine to treat various ailments. In Malaysia, P. sarmentosum roots and 
leaves are usually used to treat cough, diuretic, flu and rheumatism, headache, toothache, 
cough, asthma, pleurisy and fungi dermatitis on feet (Perry, 1981; Muhamad & Mustafa, 
2010).  
  
 In Thailand, the whole plant is utilized as expectorant, antispasmodic, enhancing 
appetite, antiflatulence, to treat diabetes, muscle pain, asthma and cough. The roots are 
used as stomachic and carminative whereas the leaves are used as carminative, to relieve 
headache and bone pain (Ridtitid et al., 1998; Muhamad & Mustafa, 2010). The roots 
are chewed together with betel nut to relieve cough and asthma, with ginger to treat 
toothache or with nutmeg and ginger to cure pleurisy. In the Chinese traditional 
medicine, P. sarmentosum leaf is used to cure fever and indigestion (Wee, 1992).  
 
2.1.4  Chemical Constituents 
Various constituents from different parts of P. sarmentosum have been identified 
with the major constituents are amide alkaloids, phenylpropanoids, pyrones, flavonoids, 
sterols and neolignans. Eight amides, two lignans and four other compounds were 
isolated from the hexane and methanol extracts of P. sarmentosum fruits including 
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pellitorine, guineensine, brachystamide B, sarmentine, brachyamide B, 1-piperettyl 
pyrrolidine, 3’,4’,5’-trimethoxycinnamoyl pyrrolidine, sarmentosine, (+)-asarinin, 
sesamin, 1-(3,4-methylenedioxyphenyl)-1E-tetradecene, methyl piperate, β-sitosterol 
and stigmasterol (Rukachaisirikul et al., 2004). Niamsa et al., (1983), Likhitwitayawuid 
et al., (1988), Masuda et al., (1991), Aunpak et al., (1997) and Parmar et al., (1997) 
reported (2E,4E)-N-isobutyldecadienamide, N-(2-phenylpropanoyl) pyrrole, 1-allyl-2,6-
demethoxy-3,4-methylenedioxybenzene, asaricin, α-asarone, β-asarone, γ-asarone, 
hydrocinnamic acid, sitosterol and oxalic acid were present in P. sarmentosum. Two 
amides were isolated from the aerial parts which were 2E,4E-diene-isobutylamides and 
N-2’-methylbutyl-2E,4E-decadieneamide (Stöhr et al., 1999). Naringenin was isolated 
from the methanol extract of P. sarmentosum leaf (Subramanian et al., 2003). According 
to Azizah et al. (2012), rutin and vitexin were the main flavonoids present in P. 
sarmentosum leaf aqueous extract. Thirty one compounds have been identified from the 
essential oil of P. sarmentosum which the main constituents are sesquiterpenes 
hydrocarbons (β-caryophyllene), oxygenated sesquiterpenes (spathilenol), myristicin and 
(E,E)-farnesol. α-phellandrene present in small parts of the oil (Chieng et al., 2008). 
Alkaloid, named nitrosoimino-2,4,5-trimethoxybenzene was identified from the hexane 
extract of the plant root (Ee et al., 2009). Bokesch et al. (2011) isolated langkamide, 
piplartine and 3,4,5-trimethoxycinnamic acid from P. sarmentosum stem and roots. The 
summary of chemical constituents from P. sarmentosum is given in Figure 2.2 and Table 
2.1. 
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Figure 2.2 Chemical constituents of P. sarmentosum. 
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Figure 2.2 (continued) Chemical constituents of P. sarmentosum. 
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Figure 2.2 (continued) Chemical constituents of P. sarmentosum. 
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Figure 2.2 (continued) Chemical constituents of P. sarmentosum. 
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Figure 2.2 (continued) Chemical constituents of P. sarmentosum. 
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Figure 2.2 (continued) Chemical constituents of P. sarmentosum. 
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Table 2.1 Chemical constituents of P. sarmentosum. 
Constituent Plant part Types of extract Reference 
Pellitorine (1) Root Ethanol  (Tuntiwachwuttikul et al., 2006) 
Brachystamide B (2) Root Ethanol  (Tuntiwachwuttikul et al., 2006) 
Sarmentine (3) Root Ethanol  (Tuntiwachwuttikul et al., 2006) 
Brachyamide B (4) Fruit Hexane (Rukachaisirikul et al., 2004) 
Sarmentosine (5) Fruit Methanol (Rukachaisirikul et al., 2004) 
(+) asarinin (6) Fruit Hexane (Rukachaisirikul et al., 2004) 
Stigmasterol (7) Root Ethanol  (Tuntiwachwuttikul et al., 2006) 
α-phellandrene (8) Root Ethanol  (Tuntiwachwuttikul et al., 2006) 
3-Phenyl-1-pyrrol-1-yl-propan-1-one (9) Root Ethanol  (Tuntiwachwuttikul et al., 2006) 
Sarmentamide A (10) Root Ethanol  (Tuntiwachwuttikul et al., 2006) 
Sarmentamide B (11) Root Ethanol  (Tuntiwachwuttikul et al., 2006) 
Horsfieldin (12) Root Ethanol  (Tuntiwachwuttikul et al., 2006) 
Naringenin (13) Leaf Methanol (Subramaniam et al., 2003) 
Hydrocinnamic acid (14) Fruit Petroleum ether (Niamsa et al., 1983) 
α-asarone (15) Fruit Not applicable (Likhitwitayawuid et al., 1988) 
β-asarone (16) 
γ-asarone (17) 
Asaraldehyde (18) 
Fruit 
Leaf 
Fruit 
Essential oil 
Not applicable 
Not applicable 
(Aunpak et al., 1997) 
(Masuda et al., 1991) 
(Likhitwitayawuid et al., 1988) 
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Table 2.1 (continued) 
Constituent Plant part Types of extract Reference 
1-allyl-2,6-dimethoxy-3,4-
methylenedioxybenzene (19) 
1, 2-dimethoxy-4-(1-propenyl)-benzene (20) 
Myristicin (21) 
nitrosoimino-2,4,5-trimethoxybenzene (22) 
1-allyl-2-methoxy-3,4-
methylenedioxybenzene (23)         
10-Epi-γ-eudesmol (24) 
Seychellene (25) 
Delta-cadinene (26) 
(E,E)-farnesol (27) 
1-Allyl-2-methoxy-4,5- 
methylenedioxybenzene (28)  
Sarmentamide C (29) 
(+) sesamin (30) 
β-caryophyllene (31) 
β-sitosterol (32) 
Vitexin (33) 
Leaf 
 
Not applicable 
Leaf and stem 
Root 
 
Root 
Leaf 
Leaf 
Not applicable 
Leaf 
 
Leaf 
Root 
Fruit 
Leaf 
Fruit 
Leaf 
Not applicable 
 
Essential oil 
Essential oil 
Hexane 
 
Ethanol 
Essential oil 
Essential oil 
Essential oil 
Essential oil 
 
Not applicable 
Ethanol 
Hexane 
Essential oil 
Hexane 
Water 
(Masuda et al., 1991) 
 
(Song et al., 2006) 
(Qin et al., 2010) 
(Ee et al., 2009) 
 
(Tuntiwachwuttikul et al., 2006) 
(Chieng et al., 2005) 
(Chieng et al., 2005) 
(Song et al., 2006) 
(Chieng et al., 2008) 
 
(Masuda et al., 1991) 
(Tuntiwachwuttikul et al., 2006) 
(Rukachaisirikul et al., 2004) 
(Chieng et al., 2008) 
(Rukachaisirikul et al., 2004) 
(Azizah et al., 2012) 
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Table 2.1 (continued) 
Constituent Plant part Types of extract Reference 
3,4,5-trimethoxycinnamic acid (34) 
 
Langkamide (35) 
 
Piplartine (36) 
 
Guineensine (37) 
Root and stem 
 
Root and stem 
 
Root and stem 
 
Fruit 
Dichloromethane and 
methanol 
Dichloromethane and 
methanol 
Dichloromethane and 
methanol 
Hexane 
(Bokesch et al., 2011) 
 
(Bokesch et al., 2011) 
 
(Bokesch et al., 2011) 
 
(Rukachaisirikul et al., 2004) 
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2.1.5  Pharmacological Activities 
 Based on the traditional knowledge and medicinal benefits of P. sarmentosum, 
the plant has been investigated for a range of pharmacological activities. P. 
sarmentosum leaf methanol extract showed potent antioxidant activity with index of 
antioxidant 13 ± 0.84 using β-carotene bleaching method. The antioxidant properties is 
due to the presence of total phenolics, carotenes, xanthophylls, tannins, vitamin C and 
vitamin E in the extract (Chanwitheesuk et al., 2005). The methanol extract also showed 
high antioxidant activity, approximately 88% using xanthine/xanthine oxidase 
superoxide scavenging assay compared to the standard, superoxide dismutase. Further 
fractionation was performed and the scavenging activity of the active fractions 7 and 8 
(71.3% inhibition) were suggested due to the isolated compound, naringenin which 
exhibited 75.7% scavenging activity (Subramaniam et al., 2003). Hussain et al. (2009a), 
reported that the aqueous and ethanol extracts of root, stem, leaf and fruit of P. 
sarmentosum exhibited moderate to mild antioxidant activities using 2,2-diphenyl-1-
picrylhydrazyl (DPPH) and β-carotene linoleate model. Two extraction methods, 
aqueous and boiled aqueous extracts of P. sarmentosum leaf exerted moderate to low 
antioxidant activity when evaluated using DPPH (15.44% and < 40%), FRAP (377.41 
and 98.76 mmol) and β-carotene (19.04% and 13.15%) assays, respectively. These 
activities were suggested due to the high presence of ascorbic acid, phenolics and 
flavonoids content (Sumazian et al., 2010). Another study by Amran et al. (2011), 
mentioned that aqueous extract of P. sarmentosum leaf showed weak dose dependent 
antioxidant activity using DPPH assay with the IC50 calculated approximately 27.12 
mg/mL.   
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 Atiax et al. (2011) studied the antibacterial activity of three amides named 3-
(3’,4’,5’-trimethoxyphenylpropanoyl)-pyrrolidine, N-3-(phenylpropanoyl)-pyrrole and 
3-(4’-methoxyphenylpropanoyl)-pyrrole and a sterol (β-sitosterol) isolated from the 
hexane extract of aerial parts of P. sarmentosum against Bacillus subtilis, 
Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa using disc 
diffusion method. Among the constituents studied, only 3-(3’,4’,5’-
trimethoxyphenylpropanoyl)-pyrrolidine, N-3-(phenylpropanoyl)-pyrrole and β-
sitosterol showed antibacterial activities against B. subtilis and S. aureus and no activity 
were recorded against E. coli and P. aeruginosa. Methanol extract of P. sarmentosum 
was reported to exert antibacterial activity against S. aureus, methicillin resistant S. 
aureus (MRSA) and P. aeruginosa with MIC values of 2000, 1000 and 2000 µg/disc, 
respectively. The inhibition zone calculated was 9, 8 and 12 mm, respectively. However, 
no activity was observed against E. coli and Klebsiella pneumoniae (Zaidan et al., 
2005). Another study by Vaghasiya et al. (2007) on antibacterial activity of P. 
sarmentosum methanol extract against 15 clinically important bacterial strains S. aureus 
(Sa-1), S. aureus (Sa-2), S. epidermidis, Micrococcus flavus, B. cereus, B. subtilis, K. 
aerogenes, K. pneumoniae, E. coli, Citrobacter freundii, Corynebacterium rubrum, P. 
aeruginosa, S. typhimurium, Proteus mirabilis and P. vulgaris showed no activity 
against all strains evaluated. Four phenylpropanoids isolated from P. sarmentosum 
leaves were reported to show antimicrobial activity against Escherichia coli and Bacillus 
subtilis (Masuda et al., 1991). Aromatic alkenes and amides isolated from hexane and 
methanol P. sarmentosum fruit extracts were studied for antituberculosis activity. The 
study reported that sarmentine, 1-piperettyl pyrrolidine, pellitorine, guineensine, 
brachyamide-B and 1-(3,4-methylenedioxyphenyl)-1E-tetradecene exhibited 
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antibacterial activity against Mycobacterium tuberculosis with MIC ≥ 25 µg/mL 
(Rukachaisirikul et al., 2004). Methanol extract of P. sarmentosum whole part also 
showed weak antituberculosis activity with MIC value of 800 µg/mL as compared to the 
positive control, isoniazid which has MIC value of 0.078 µg/mL  (Mohamad et al., 
2010).  
 
 The plant was also investigated for antifungal activity. The antifungal activity of 
13 Thai herbs including P. sarmentosum against Aspergillus niger, Aspergillus oryzae 
and Penicillium sp. using agar well diffusion method were determined. From the study, 
it was mentioned that P. sarmentosum ethanol extract was active against A. niger and 
did not show activity against A. oryzae and Penicillium sp. (Wanchaitanawong et al., 
2005). Methanol extract of P. sarmentosum exhibited antifungal activity against 
Microsporum canis, Aspergillus flavus, Candida albicans, Trichophyton rubrum and 
Trichophyton mentagrophytes  using standard disc diffusion method with inhibition zone 
of 9.0, 9.0, 8.0, 9.0 and 9.0, respectively (Nazmul et al., 2011). Two amides isolated 
from ethanol extract of the root of P. sarmentosum were reported to exhibit antifungal 
activity against Candida albicans with IC50 of 41.82 and 32.82 µg/mL, respectively 
(Tuntiwachwuttikul et al., 2006).  
 
 Despite showing antibacterial activity, a number of studies have reported that the 
plant exhibited good activities as larvicidal, antiplasmoid and antiamoebic agent. 
Ethanol extract from the whole plant exhibited larvicidal activity with LC50 value at 4.06 
ppm against early fourth instar larvae of Aedes aegypti. The authors suggested that 
structural deformation of anal papillae of the larvae as mode of larvicidal effect of the 
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extract (Chaithong et al., 2006). Rukachaisirikul et al. (2004) reported that sarmentine 
and 1-piperettyl pyrrolidine which were isolated from ethanol root extract of P. 
sarmentosum showed antiplasmodial activity against Plasmodium falciparum using in 
vitro micro culture radioisotope technique with IC50 values of 18.9 and 6.5 µg/mL 
respectively. In vivo study of P. sarmentosum root methanol extract showed that at a 
dose of 1000 mg/kg, it exerted antiamoebic activity against Entamoeba histolytica 
induced caecal amoebiasis in mice (Sawangjaroen et al., 2004). Qin et al. (2010) 
reported that essential oils of P. sarmentosum leaves presented antifeedant and 
fumigation activities against the Brontispa longissima eggs and larvae. The main 
compounds isolated from the essential oils which are myristicin (65.22%) and trans-
caryophyllene (13.89%) also showed significant effect in both activities. 
 
 The plant is reported to have anti-inflammatory activity in a number of in vivo 
studies. Aqueous extract from leaf of P. sarmentosum exhibited anti-inflammatory 
activity in dose dependent manner in carrageenan-induced paw edema and rabbit 
enzyme-linked immunosorbent assay (ELISA). The onset of anti-inflammatory action 
started 3 hours after administration of extracts in both models (Zakaria, et al., 2010; 
Amran et al., 2011). Ethanol extract from root of P. sarmentosum was reported to exert a 
potent anti-inflammatory activity using ethyl phenylpropiolate-induced ear edema and 
carrageenan-induced edema in rats. In the chronic inflammatory model using cotton 
pellet-induced granuloma, the extract was able to reduce the transudative and granuloma 
weights in rats (Sireeratawong et al., 2010). In another study, methanol extract from 
leaves of P. sarmentosum at a dose of 300 mg/kg significantly reduced the paw edema 
volume by 44.56-63.63% in first to third hour using the dextran-induced edema model. 
24 
 
The extract at a dose of 300 mg/kg was able to reduce the edema volume by 47.41% in 
the first hour and 24.78% after three hour (Vaghasiya et al., 2007). 
 
In antinociceptive study, aqueous extract from leaves of P. sarmentosum was 
evaluated using abdominal constriction and hot plate test. The extract at the doses of 30, 
100 and 300 mg/kg exhibited potent antinociceptive effect with percentage of analgesia 
of 18.1, 45.2 and 61.6%, respectively (Zakaria et al., 2010). P. sarmentosum root 
ethanol extract also showed antinociceptive activity at doses of 300, 600 and 1200 
mg/kg in dose dependent manner. Apart from that, the extract was successfully reduced 
rectal temperature of pyrexia induced by brewer’s yeast in rats suggested that it contains 
antipyretic activity (Sireeratawong et al., 2010). Methanol and aqueous extracts from 
leaves of P. sarmentosum did not show antipyretic activity using brewer’s yeast induced 
pyrexia in rats (Ridtitid et al., 2007; Daud et al., 2016). 
 
Peungvicha et al. (1998) evaluated the hypoglycemic activity of water extract 
from P. sarmentosum whole plant in normal and streptozotocin-induced diabetic rats. 
Single dose of oral administration at 125 and 250 mg/kg significantly reduced the 
plasma glucose level in normal rats whereas repeated dose at 125 mg/kg for seven days 
was significantly reduced the glucose level in diabetic rats. A 28 days in vivo study of 
streptozotocin-induced diabetic rats showed that treatment with P. sarmentosum leaves 
water extract at dose of 125 mg/kg was able to reduce the blood sugar level from 26.58 – 
23.33 mmol in the rats. Histology analysis of the rats kidney showed that the extract was 
able to improve the inflammatory cells infiltration and glomeruli, thus suggested that it 
may prevent the diabetic nephropathy complication (Hussan et al., 2013). Aqueous 
